Paragon Pharmaceuticals builds innovative pharmaceutical companies that utilize the best talent and technologies to target specific healthcare needs.
- Our companies are doing studies in Phase I, II, III and IV
- We are aspiring to deliver innovation to this process to develop drugs that will improve the health of those with diseases
- Building a strong infrastructure to develop novel therapeutics
Paragon Pharmaceuticals’ commitment to alleviating suffering and improving patients’ lives goes beyond commercial drug development.
“Paragon Pharmaceuticals is a company where patients, science and solutions come first.”
Paragon Pharmaceuticals’ portfolio companies are leading the future of pharma in the fields of rare diseases, gastrointestinal therapy, oncology, pain management, central nervous system disorders, and drug development using gene technology. Paragon Pharmaceuticals companies are designed, staffed and supported to enable rapid progress and breakthrough innovation. Currently our companies have products at various stages in their life cycles, from clinical development to commercial pharmaceutical drugs.
By developing separate companies we are able to focus on the therapeutic class as needed to develop and sustain products.
Patients are the focus of everything we do. Paragon Pharmaceuticals and its portfolio companies work at the grassroots level with patients and advocacy groups to identify needs and opportunities within specific disease states. We invest to bring the best science and solutions to the cause of improving patients’ lives, often in therapeutic areas that are outside the scope of traditional pharma companies.